582
Views
18
CrossRef citations to date
0
Altmetric
Quality of Life and Sexual Function in PCOS

Quality of life and sexual function in women with polycystic ovary syndrome: a comprehensive review

ORCID Icon & ORCID Icon
Pages 96-103 | Received 04 Jul 2019, Accepted 18 Sep 2019, Published online: 27 Sep 2019

References

  • Azziz R, Adashi EY. Stein and Leventhal: 80 years on. Am J Obstet Gynecol. 2016;214(2):247.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Working Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
  • National Institute of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. Final report. 2012. Executive summary at https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf, last accessed Nov 1, 2015.
  • Blagojevic IP, Eror T, Pelivanovic J, et al. Women with polycystic ovary syndrome and risk of cardiovascular disease. J Med Biochem. 2017;36(3):259–269.
  • Lizneva D, Walker W, Brakta S, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
  • Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013;78(8):755–760.
  • Miklyaeva I, Danilova I. Topical issues of polycystic ovary syndrome in women of reproductive age. Young Sci. 2018;24:285–289.
  • Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what's new? Adv Clin Exp Med. 2017;26(2):359–367.
  • Shilin D. Polycystic ovary syndrome: International Diagnostic Consensus (2003) and modern theory of therapy. Consilium Medicum. 2004;06(9):6–11.
  • Balen AH. Polycystic ovary syndrome (PCOS). Obstet Gynecol. 2017;19:119–129.
  • Podfigurna-Stopa A, Luisi S, Regini C. Mood disorders and quality of life in polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(6):431–434.
  • Dokras A, Sarwer DB, Allison KC, et al. Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab. 2016;101(8):2966–2974.
  • Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–2286.
  • Ware J, Sherbourne C. The MOS 36-Item Short Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
  • Jones G, Benes K, Clark T, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation . Hum Reprod. 2004;19(2):371–728.
  • Deeks AA, Gibson-Helm ME, Paul E, et al. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26(6):1399–1407.
  • Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888–899.
  • Farkas J, Rigó A, Demetrovics Z. Psychological aspects of the polycystic ovary syndrome. Gynecol Endocrinol. 2014;30(2):95–99.
  • Bazarganipour F, Taghavi SA, Montazeri A, et al. The impact of polycystic ovary syndrome on the health-related quality of life: a systematic review and meta-analysis. Iran J Reprod Med. 2015;13(2):61–70.
  • Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf). 2007;66(3):373–379.
  • Jones GL, Palep-Singh M, Ledger WL, et al. Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 2010;8(1):149–148.
  • Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form - 36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–86.
  • Stefanaki C, Bacopoulou F, Livadas S, et al. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial. Stress. 2015;18(1):57–66.
  • Rodrigues CEG, Ferreira L. D L, Jansen K, et al. Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index. Rev Bras Ginecol Obstet. 2012;34(10):442–446.
  • Misso M, Boyle J, Norman R, et al. Development of evidenced-based guidelines for PCOS and implications for community health. Semin Reprod Med. 2014;32(03):230–240.
  • Stapinska-Syniec A, Grabowska K, Szpotanska-Sikorska M, et al. Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(7):597–600.
  • Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry. 2003;54(3):330–337.
  • Borghi L, Leone D, Vegni E, et al. Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical and socio-demographic factors. J Psychosom Obstet Gynaecol. 2018;39(2):128–137.
  • Scaruffi E, Gambineri A, Cattaneo S, et al. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol (Lausanne). 2014; 5:185.
  • Tan J, Wang QY, Feng GM, et al. Increased risk of psychiatric disorders in women with polycystic ovary syndrome in Southwest China. Chin Med J. 2017;130(3):262–266.
  • Asik M, Altinbas K, Eroglu M, et al. Evaluation of affective temperament and anxiety-depression levels of patients with polycystic ovary syndrome. J Affect Disord. 2015;185:214–218.
  • Annagür BB, Kerimoglu ÖS, Tazegül A, et al. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2015;41(8):1229–1233.
  • Carmina E, Rosato F, Janni A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2–6.
  • Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091.
  • Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J. 1993;69(809):186–189.
  • Shulman LH, Derogatis L, Spielvogel R, et al. Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol. 1992;27(2 Pt 1):178–181.
  • Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–919.
  • Farrell-Turner KA. Women's health providers: don't forget about polycystic ovary syndrome. Am Psychol. 2015;70(1):49–50.
  • Lara LA, Ramos FK, Kogure GS, et al. Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome. J Sex Med. 2015;12(7):1584–1590.
  • Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011;26(12):3339–3345.
  • Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.
  • Barry JA, Qu F, Hardiman PJ. An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS). Medical Hypotheses. 2018;110:42–45.
  • Yavari M, Khodabandeh F, Tansaz M, et al. A neuropsychiatric complication of oligomenorrhea according to Iranian traditional medicine. Iran J Reprod Med. 2014;12(7):453–458.
  • Dokras A, Clifton S, Futterweit W, et al. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012;97(1):225–230.
  • Dokras A. Mood and anxiety disorders in women with PCOS//Steroids. Steroids. 2012;77(4):338–341.
  • Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
  • Hollinrake E, Abreu A, Maifeld M, et al. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369–1376.
  • Mansson M, Holte J, Landin-Wilhelmsen K, et al. Women with polycystic ovary syndrome are often depressed or anxious-a case control study. Psychoneuroendocrinology. 2008;33(8):1132–1138.
  • Lee I, Cooney LG, Saini S, et al. Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril. 2017;107(3):796–802.
  • Shi X, Zhang L, Fu S, et al. Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome. Arch Gynecol Obstet. 2011;284(3):773–778.
  • Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril. 2010;93(7):2421–2423.
  • Veltman-Verhulst SM, Boivin J, Eijkemans MJ, et al. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update. 2012;18(6):638–651.
  • Trent ME, Rich M, Austin SB, et al. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome. Implications for quality of life. J Pediatr Adolesc Gynecol. 2003;16(1):33–37.
  • Ferraresi SR, Lara LA, Reis RM, et al. Changes in sexual function among women with polycystic ovary syndrome: a pilot study. J Sex Med. 2013;10(2):467–473.
  • Norozzadeh M, Tehrani FR, Mobarakabadi SS, et al. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study. Int J Impot Res. 2017;29:1–6.
  • Shafti V, Shahbazi S. Comparing sexual function and quality of life in polycystic ovary syndrome and healthy women. J Fam Reprod Health. 2016;10(2):92–98.
  • Pastoor H, Timman R, de Klerk C, et al. Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biomed Online. 2018;37(6):750–760.
  • Bancroft J. Androgens and sexual function in men and women In: Bagatell CJ, Bremmer WJ, eds. Androgens in health and disease. Totowa: Humana Press. 2003. 258–290.
  • Battaglia C, Nappi RE, Mancini F, et al. PCOS, sexuality, and clitoral vascularisation: a pilot study. J Sex Med. 2008;5(12):2886–2894.
  • Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr. 2017;6(4):248–255.
  • Palomba S, Santagni S, Falbo A, et al. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745–763.
  • Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(12):4655–4663.
  • Cinar N, Harmanci A, Demir B, et al. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum Reprod. 2012;27(6):1840–1845.
  • Banting LK, Gibson-Helm M, Polman R, et al. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51.
  • Moran LJ, March WA, Whitrow MJ, et al. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum Reprod. 2015;30(2):466–472.
  • Greenwood EA, Pasch LA, Shinkai K, et al. Putative role for insulin resistance in depression risk in polycystic ovary syndrome. Fertil Steril. 2015;104(3):707–714.
  • Hung JH, Hu LY, Tsai SJ, et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One. 2014;9(5):e97041.
  • Nasiri Amiri F, Ramezani Tehrani F, Simbar M, et al. The experience of women affected by polycystic ovary syndrome: a qualitative study from Iran. Int J Endocrinol Metab. 2014;12(2):e13612.
  • Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. Part 2. Endocr Pract. 2015;21(12):1415–1426.
  • Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.